Cargando…
A dual-channel endoscope for quantitative imaging, monitoring, and triggering of doxorubicin release from liposomes in living mice
Doxorubicin (Dox) is approved for use in liposomal form for the treatment of ovarian cancer. We previously developed a long-circulating Dox formulation in liposomes containing small amounts of porphyrin-phospholipid, which enables on-demand drug release with near-infrared irradiation. In this study,...
Autores principales: | Kress, Jeremy, Rohrbach, Daniel J., Carter, Kevin A., Luo, Dandan, Poon, Chien, Aygun-Sunar, Semra, Shao, Shuai, Lele, Shashikant, Lovell, Jonathan F., Sunar, Ulas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686102/ https://www.ncbi.nlm.nih.gov/pubmed/29138489 http://dx.doi.org/10.1038/s41598-017-15790-y |
Ejemplares similares
-
ROS-responsive liposomes with NIR light-triggered doxorubicin release for combinatorial therapy of breast cancer
por: Yi, Hanxi, et al.
Publicado: (2021) -
Quantification of PpIX concentration in basal cell carcinoma and squamous cell carcinoma models using spatial frequency domain imaging
por: Sunar, Ulas, et al.
Publicado: (2013) -
Alginate Microspheres Containing Temperature Sensitive Liposomes (TSL) for MR-Guided Embolization and Triggered Release of Doxorubicin
por: van Elk, Merel, et al.
Publicado: (2015) -
Sphingomyelin Liposomes Containing Porphyrin-phospholipid for Irinotecan Chemophototherapy
por: Carter, Kevin A, et al.
Publicado: (2016) -
Folate-Targeted Nanoliposomal Chemophototherapy
por: Chitgupi, Upendra, et al.
Publicado: (2023)